O
Ole Faergeman
Researcher at Aarhus University
Publications - 77
Citations - 25445
Ole Faergeman is an academic researcher from Aarhus University. The author has contributed to research in topics: Simvastatin & Cholesterol. The author has an hindex of 35, co-authored 77 publications receiving 25007 citations. Previous affiliations of Ole Faergeman include Aarhus University Hospital.
Papers
More filters
Journal Article
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Anders G. Olsson,Jjv McMurray,Gudmundur Thorgeirsson,C Spaulding,J Slattery,Kalevi Pyörälä,Ole Faergeman,RA Wright,Kåre Berg,Lars Wilhelmsen,Terje R. Pedersen,Tatu A. Miettinen,Harvey D. White,John Kjekshus,Michael Gnant +14 more
Journal ArticleDOI
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.
Guy De Backer,Ettore Ambrosioni,Knut Borch-Johnsen,Carlos Brotons,Renata Cifkova,Jean Dallongeville,Shah Ebrahim,Ole Faergeman,Ian D. Graham,Giuseppe Mancia,Volkert Manger Cats,Kristina Orth-Gomér,Joep Perk,Kalevi Pyörälä,Jose L. Rodicio,Susana Sans,Vedat Sansoy,Udo Sechtem,Sigmund Silber,Troels Thomsen,David R. Wood,Christian Albus,Nuri Bages,Gunilla Burell,Ronan M. Conroy,Hans Christian Deter,Christoph Hermann-Lingen,Steven Humphries,Anthony Fitzgerald,Brian Oldenburg,Neil Schneiderman,Antti Uutela,Redford Williams,John Yarnell,Silvia G. Priori,Maria Angeles Alonso Garcia,Jean-Jacques Blanc,Andrzej Budaj,Martin R. Cowie,Veronica Dean,Jaap W. Deckers,Enrique Fernandez Burgos,John Lekakis,Bertil Lindahl,Gianfranco Mazzotta,Keith McGregor,João Morais,Ali Oto,Otto A. Smiseth,Hans-Joachim Trappe,Carl-David Agardh,Jean-Pierre Bassand,Maciek Godycki-Cwirko,Anthony M. Heagerty,Robert J. Heine,Philip Home,Silvia Priori,Pekka Puska,Mike Rayner,Annika Rosengren,Mario Sammut,James Shepherd,Johannes Siegrist,Maarten L. Simoons,Michal Tendera,Alberto Zanchetti +65 more
TL;DR: It is of great importance that guidelines and recommendations are presented in formats that are easily interpreted, and their implementation programmes must also be well conducted.
Journal ArticleDOI
European guidelines on cardiovascular disease and prevention in clinical practice.
Guy De Backer,Ettore Ambrosioni,Knut Borch-Johnsen,Carlos Brotons,Renata Cifkova,Jean Dallongeville,Shah Ebrahim,Ole Faergeman,Ian D. Graham,Giuseppe Mancia,Volkert Manger Cats,Kristina Orth-Gomér,Joep Perk,Kalevi Pyörälä,Jose L. Rodicio,Susana Sans,Vedat Sansoy,Udo Sechtem,Sigmund Silber,Troels Thomsen,David A. Wood,other Societies on Cardiovascu +21 more
TL;DR: Authors/Task Force Members: Massimo F. Piepoli (Chairperson), Arno W. Hoes (Co-Chairperson) (The Netherlands), Stefan Agewall (Norway) 1, Christian Albus (Germany)9, Carlos Brotons (Spain)10, Alberico L. Catapano (Italy)3, Marie-Therese Cooney (Ireland)1, Ugo Corrà (Italy).
Journal ArticleDOI
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
Pyŏrälä K,Terje R. Pedersen,John Kjekshus,Ole Faergeman,Anders G. Olsson,Gudmundur Thorgeirsson +5 more
TL;DR: It is suggested that cholesterol lowering with simvastatin improves the prognosis of diabetic patients with CHD and the absolute clinical benefit achieved by cholesterol lowering may be greater in diabetic than in nondiabetic patients withCHD because diabetic patients have a higher absolute risk of recurrent CHD events and other atherosclerotic events.
Journal ArticleDOI
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention.
TL;DR: The Task Force has summarized the most important clinical issues on coronary heart disease prevention on which there is good agreement in order to give cardiologists and physicians, and other health care professionals, the best possible advice to facilitate their work on coronaryHeart disease prevention.